Drawing for EUROAPI ACTIVE SOLUTIONS FOR HEALTH

USPTO serial 79324949

EUROAPI ACTIVE SOLUTIONS FOR HEALTH

Reviewed by CopyMark Law Group

Reg. 7077442Status 700Registered
Filing date
Status date
Registration date
Jun 13, 2023
Examiner
HOWARD, PARKER WALDRIP
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EUROAPI ACTIVE SOLUTIONS FOR HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen Lim

Karen Lim Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry, research and science; bio-organic products in the nature of biochemical preparation for use in industry, research and science; active chemical and bio-organic ingredients in the nature of biochemical preparation for use in industry, research and scienceACTIVE—
005Pharmaceutical preparations for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye disease, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; metabolic diseases, psychiatric disorders, muscular diseases; hygienic products for medicine namely bacterial preparations and disinfectants; dietetic foods for medical or veterinary use; food supplements for humans and animals; disinfectantsACTIVE—
040Treatment of chemicals, namely, custom manufacture and custom synthesis of pharmaceuticals and active pharmaceutical ingredients; custom manufacture of pharmaceuticalsACTIVE—
042Research and development services in the field of health and biotechnology, namely research with respect to the development of new active ingredients; research for identifying means of industrial synthesis of pharmaceutical products; conducting of industrial quality studies, namely scientific study and research in the area of industrial quality; research relating to industrial quality namely scientific research in the area of industrial quality; design and development of methods for analyzing chemicals and pharmaceutical and bio-organic products; development and scientific study of analytical methods to control chemical reactions; research and development services applied in the pharmaceutical and chemical fields belonging to others in the nature of the development of chemical or biochemical synthesis pathways; research and development in the field of pharmaceutical, chemical, agrochemical and industrial processes; scientific and industrial analysis services; scientific analysis services for the identification and physical characterization of chemical molecules; design of development batches or commercial batches for others in the pharmaceutical and chemical fields; formulation and pre-formulation development for pharmaceutical, chemical and agrochemical products; engineering services in the field of formulation, evaluation, processes, estimation and projects in the scientific and industrial fields, and the chemical and pharmaceutical fields; scientific study and research services in the field of industrial safety; conducting chemical surveying with respect to fundamental and industrial technologies especially for chemical and pharmaceutical or organic products and their processingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 10, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 14, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 14, 2023FIMPFINAL DISPOSITION PROCESSED—
Sep 13, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 13, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 13, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 24, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 5, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 5, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 29, 2023GPNXNOTIFICATION PROCESSED BY IB—
Mar 28, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 28, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 8, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 8, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 8, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 21, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 16, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 15, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 15, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 30, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 30, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 30, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 19, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 19, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 19, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 19, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 19, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 19, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Aug 19, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 19, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 19, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 10, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 16, 2022RFNTREFUSAL PROCESSED BY IB—
Apr 21, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 21, 2022RFRRREFUSAL PROCESSED BY MPU—
Mar 15, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2022RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Feb 5, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 4, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 2, 2022DOCKASSIGNED TO EXAMINER—
Nov 12, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 8, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 4, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance